Metabolomic changes and protective effect of L-carnitine in rat kidney ischemia/reperfusion injury

Kidney and Blood Pressure Research

Volumn 35, Issue 5, 2012, Pages 373-381

  Liu, Ye ^a   Yan, Shikai ^b   Ji, Chengcheng ^a   Dai, Weixing ^c   Hu, Wenjuan ^a   Zhang, Weidong ^b,c   Mei, Changlin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Carnitine; Ischemia reperfusion; Metabolomics; Oxidative stress; Phosphocholine

Indexed keywords

3 NITROTYROSINE; ACETYLCARNITINE; CARNITINE; CREATININE; FATTY ACID; LYSOPHOSPHOLIPID; MALONALDEHYDE; NITROGEN; PHOSPHOLIPASE A2; SUPEROXIDE DISMUTASE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY INJURY; KIDNEY ISCHEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; CARNITINE; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; MALE; MALONDIALDEHYDE; METABOLOMICS; OXIDATIVE STRESS; PHOSPHOLIPASES A2, SECRETORY; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; VITAMIN B COMPLEX;

EID: 84859413982     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000336171     Document Type: Article

References (34)

1. Thadhani R, Pascual M, Bonventre JV, et al: Acute renal failure. N Engl J Med 1996; 334: 1448-1460. (Pubitemid 126590563)
2. Edelstein CL, Ling H, Schrier RW, et al: The nature of renal cell injury. Kidney Int 1997; 51: 1341-1351. (Pubitemid 27239881)
3. Kribben A, Wieder ED, Wetzels JFM, et al: Evidence for role of cytosolic free calcium in hypoxia-induced proximal tubule injury. J Clin Invest 1994; 93: 1922-1929. (Pubitemid 24143069)
4. Goligorsky MS, Brodsky SV, Noiri E, et al: Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 2002; 61: 855-861. (Pubitemid 34175452)
5. Haq M, Norman J, Saba SR, et al: Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 1998; 9: 614-619.
6. Nakamura H, Nemenoff RA, Gronich JH, et al: Subcellular characteristics of phospholipase A2 activity in the rat kidney. J Clin Invest Volume 1991; 87: 1810-1818.
7. Bazan NG: Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 1970; 218: 1-10.
8. Sen A, Miller JC, Reynolds R, et al: Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion. J Clin Invest 1988; 82: 1333-1338.
9. Otamiri T, Franzen L, Lindmark D, et al: Increased phospholipase A2 and decreased lysophospholipase activity in the small intestinal mucosa after ischemia and revascularisation. Gut 1987; 28: 1445-1453. (Pubitemid 17164077)
10. Eisei N, Akihide N, Koji U, et al: Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 2001; 281:F948-F957.
11. Nicholson JK, Wilson ID: Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2003; 2: 668-676. (Pubitemid 37361770)
12. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Grainger DJ: Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 2002; 8: 1439-1444. (Pubitemid 36019430)
13. Makinen VP, Soininen P, Forsblom C, et al: 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 2008; 4: 167.
14. Woodcock J: The prospects for 'Personalized Medicine' in drug development and drug therapy. Clin Pharmacol Ther 2007; 81: 164-169.
15. Beger RD, Sun J, Schnackenberg LK, et al: Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharm 2010; 243: 154-166.
16. Xu J, Zhang J, Ca S, et al: Metabonomics studies of intact hepatic and renal cortical tissues from diabetic db/db mice using high-resolution magic-angle spinning 1H NMR spectroscopy. Anal Bioanal Chem 2009; 393: 1657-1668.
17. Wishart D: Metabolomics in monitoring kidney transplants. Curr Opin Nephrol Hypertens 2006; 15: 6.
18. Serkova N, Fuller TF, Klawitter J, et al: 1H-NMR-based metabolic signatures of mild and severe ischemia//reperfusion injury in rat kidney transplants. Kidney Int 2005; 67: 1142-1151. (Pubitemid 41623341)
19. Lango R, Smolenski RT, Narkiewicz M, et al: Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc Res 2001; 51: 21-29. (Pubitemid 32523051)
20. Gorur S, Bagdatoglu OT, Polat G, et al: Protective effect of L-carnitine on renal ischaemia-reperfusion injury in the rat. Cell Biochem Funct 2005; 23: 151-155. (Pubitemid 40695397)
21. Hotelling H: The generalization of Student's ratio. Ann Math Stat 1931; 2: 360-378.
22. Novgorodov SA, Gudz TI: Ceramide and mitochondria in ischemia/ reperfusion. J Cardiovasc Pharmacol 2009; 53: 198-208.
23. Paller MS, Greene EL: Role of calcium in reperfusion injury of the kidney; in Dipak KD (ed): Cellular, Biochemical, and Molecular Aspects of Reperfusion Injury. New York, Annals of the New York Academy of Sciences, 1994, p 59.
24. Dolegowska B, Pikula E, Safranow K, et al: Metabolism of eicosanoids and their action on renal function during ischaemia and reperfusion: the effect of alprostadil. Prostag Leukotr Ess 2006; 75: 403-411. (Pubitemid 44648736)
25. Sakurabayashi T, Miyazaki S, Yuasa Y, et al: L-Carnitine supplementation decreases the left ventricular mass in patients undergoing hemodialysis. Circ J 2008; 72: 926-931. (Pubitemid 351879913)
26. Tarantini G, Scrutinio D, Bruzzi P, et al: Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial. Cardiology 2006; 106: 215-223. (Pubitemid 44763174)
27. Gorur S, Bagdatoglu OT, Polat G, et al: Protective effect of L-carnitine on renal ischaemia-reperfusion injury in the rat. Cell Biochem Funct 2005; 23: 151-155. (Pubitemid 40695397)
28. Lohninger A, Pittner G, Pittner F, et al: L-carnitine: new aspects of a known compound - a brief survey. Monatsh Chem 2005; 136: 1255-1268. (Pubitemid 41095358)
29. Murray J, Oquendo CE, Willis JH, et al: Monitoring oxidative and nitrative modification of cellular proteins, a paradigm for identifying key disease related markers of oxidative stress. Adv Drug Deliv Rev 2008; 60: 1497-1503.
30. Arduini A: Carnitine and its acyl esters as secondary antioxidants? Am Heart J 1992; 123: 1726-1727.
31. Pamplona R, Portero-Otín M, Riba D, et al: Low fatty acid unsaturation: a mechanism for lowered lipoperoxidative modification of tissue proteins in mammalian species with long life spans. J Gerontol A 2000; 55:B286-B291. (Pubitemid 30368404)
32. Brown GC: Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1999; 1411: 351-369.
33. Kremser K, Stangl H, Pahan K, et al: Nitric oxideregulates peroxisomal enzyme activities. Euro J Clin Chem Clin Biochem 1995; 33: 763-774.
34. Gulcin I: Antioxidant and antiradical activities of L-carnitine. Life Sci 2006; 78: 803-811.